Home » Topics » Regulatory » Health Canada

Health Canada
RSS

Health Canada approves Strensiq for hypophosphatasia

Aug. 18, 2015

PhytoTech Medical completes acquisition of MMJ Bioscience

July 31, 2015

Health Canada clears Hydra to begin phase I study of HX-100

April 16, 2015

Novartis's LCZ-696 awarded priority review by Health Canada

March 13, 2015

PBI-4050 granted U.S. orphan drug status for IPF

Feb. 18, 2015

Health Canada updates Zelboraf labeling to advise of pancreatitis risk

Feb. 13, 2015

ProMetic receives clearance to start trial of PBI-4050 in metabolic-syndrome-associated diabetes

Jan. 29, 2015

Tekmira authorized to start phase I trial of RNAi therapeutic for HBV infection

Dec. 29, 2014

Health Canada clears Immunovaccine to conduct phase II trial of DPX-Survivac

Nov. 20, 2014

PBI-4050 cleared to commence trials in patients with diabetic kidney disease

Nov. 12, 2014

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...